1. Home
  2. ANDE vs ADPT Comparison

ANDE vs ADPT Comparison

Compare ANDE & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$71.96

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$13.54

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANDE
ADPT
Founded
1947
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
ANDE
ADPT
Price
$71.96
$13.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$75.00
$17.78
AVG Volume (30 Days)
295.2K
1.6M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.03%
N/A
EPS Growth
12.93
63.89
EPS
0.97
N/A
Revenue
$11,008,928,000.00
$276,976,000.00
Revenue This Year
$7.28
$3.98
Revenue Next Year
$3.57
$22.72
P/E Ratio
$73.57
N/A
Revenue Growth
N/A
54.77
52 Week Low
$31.84
$8.50
52 Week High
$82.11
$20.76

Technical Indicators

Market Signals
Indicator
ANDE
ADPT
Relative Strength Index (RSI) 44.75 45.10
Support Level $69.11 $12.22
Resistance Level $74.83 $15.38
Average True Range (ATR) 2.65 0.79
MACD -0.92 -0.02
Stochastic Oscillator 38.13 27.88

Price Performance

Historical Comparison
ANDE
ADPT

About ANDE Andersons Inc. (The)

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: